Literature DB >> 22180847

Effect of fiber supplementation on the microbiota in critically ill patients.

Stephen J D O'Keefe1, Junhai Ou, James P Delany, Scott Curry, Erwin Zoetendal, H Rex Gaskins, Scott Gunn.   

Abstract

AIM: To determine tolerance to fiber supplementation of semi-elemental tube feeds in critically ill patients and measure its effect on colonic microbiota and fermentation.
METHODS: Thirteen intensive care unit patients receiving jejunal feeding with a semi-elemental diet for predominantly necrotizing pancreatitis were studied. The study was divided into 2 parts: first, short-term (3-9 d) clinical tolerance and colonic fermentation as assessed by fecal short chain fatty acid (SCFA) concentrations and breath hydrogen and methane was measured in response to progressive fiber supplementation increasing from 4 g tid up to normal requirement levels of 8 g tid; second, 4 patients with diarrhea were studied for 2-5 wk with maximal supplementation to additionally assess its influence on fecal microbiota quantitated by quantitative polymerase chain reaction (qPCR) of microbial 16S rRNA genes and Human Intestinal Tract Chip (HITChip) microarray analysis. Nearly all patients were receiving antibiotics (10/13) and acid suppressants (11/13) at some stage during the studies.
RESULTS: In group 1, tolerance to progressive fiber supplementation was good with breath hydrogen and methane evidence (P = 0.008 and P < 0.0001, respectively) of increased fermentation with no exacerbation of abdominal symptoms and resolution of diarrhea in 2 of 4 patients. In group 2 before supplementation, fecal microbiota mass and their metabolites, SCFA, were dramatically lower in patients compared to healthy volunteers. From qPCR and HITChip analyses we calculated that there was a 97% reduction in the predominant potential butyrate producers and starch degraders. Following 2-5 wk of fiber supplementation there was a significant increase in fecal SCFA (acetate 28.4 ± 4.1 μmol/g to 42.5 ± 3.1 μmol/g dry weight, P = 0.01; propionate 1.6 ± 0.5 vs 6.22 ± 1.1, P = 0.006 and butyrate 2.5 ± 0.6 vs 5.9 ± 1.1, P = 0.04) and microbial counts of specific butyrate producers, with resolution of diarrhea in 3 of 4 patients.
CONCLUSION: Conventional management of critically ill patients, which includes the use of elemental diets and broad-spectrum antibiotics, was associated with gross suppression of the colonic microbiota and their production of essential colonic fuels, i.e., SCFA. Our investigations show that fiber supplementation of the feeds has the potential to improve microbiota mass and function, thereby reducing the risks of diarrhea due to dysbiosis.

Entities:  

Keywords:  Acute pancreatitis; Critical illness; Enteral nutrition; Fiber; Microbiota

Year:  2011        PMID: 22180847      PMCID: PMC3240905          DOI: 10.4291/wjgp.v2.i6.138

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  28 in total

1.  Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota.

Authors:  Vincent B Young; Thomas M Schmidt
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

2.  Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea.

Authors:  Ju Young Chang; Dionysios A Antonopoulos; Apoorv Kalra; Adriano Tonelli; Walid T Khalife; Thomas M Schmidt; Vincent B Young
Journal:  J Infect Dis       Date:  2008-02-01       Impact factor: 5.226

3.  Treatment of diversion colitis with short-chain-fatty acid irrigation.

Authors:  J M Harig; K H Soergel; R A Komorowski; C M Wood
Journal:  N Engl J Med       Date:  1989-01-05       Impact factor: 91.245

4.  Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile.

Authors:  M F De La Cochetière; T Durand; V Lalande; J C Petit; G Potel; L Beaugerie
Journal:  Microb Ecol       Date:  2008-01-22       Impact factor: 4.552

5.  Utilization of nutrients by isolated epithelial cells of the rat colon.

Authors:  W E Roediger
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

6.  Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.

Authors:  M N Choudhry; H Soran; H M Ziglam
Journal:  QJM       Date:  2008-04-14

7.  Effect of fiber source on short-chain fatty acid production and on the growth and toxin production by Clostridium difficile.

Authors:  T May; R I Mackie; G C Fahey; J C Cremin; K A Garleb
Journal:  Scand J Gastroenterol       Date:  1994-10       Impact factor: 2.423

8.  Improved extraction of PCR-quality community DNA from digesta and fecal samples.

Authors:  Zhongtang Yu; Mark Morrison
Journal:  Biotechniques       Date:  2004-05       Impact factor: 1.993

Review 9.  Nutrition and colonic health: the critical role of the microbiota.

Authors:  Stephen J D O'Keefe
Journal:  Curr Opin Gastroenterol       Date:  2008-01       Impact factor: 3.287

10.  Microbial induction of immunity, inflammation, and cancer.

Authors:  Julia B Greer; Stephen John O'Keefe
Journal:  Front Physiol       Date:  2011-01-26       Impact factor: 4.566

View more
  21 in total

1.  Microbiome as mediator: Do systemic infections start in the gut?

Authors:  Melissa Latorre; Suneeta Krishnareddy; Daniel E Freedberg
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

Review 2.  Impact of Soluble Fiber in the Microbiome and Outcomes in Critically Ill Patients.

Authors:  Carla Venegas-Borsellino; Minkyung Kwon
Journal:  Curr Nutr Rep       Date:  2019-12

3.  Relationship Between Dietary Fiber Intake and Short-Chain Fatty Acid-Producing Bacteria During Critical Illness: A Prospective Cohort Study.

Authors:  Yichun Fu; Dagmara I Moscoso; Joyce Porter; Suneeta Krishnareddy; Julian A Abrams; David Seres; David H Chong; Daniel E Freedberg
Journal:  JPEN J Parenter Enteral Nutr       Date:  2019-08-06       Impact factor: 4.016

4.  The role of butyrate in surgical and oncological outcomes in colorectal cancer.

Authors:  Roy Hajjar; Carole S Richard; Manuela M Santos
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-01-06       Impact factor: 4.052

5.  Microbiome changes associated with acute and chronic pancreatitis: A systematic review.

Authors:  L Brubaker; S Luu; Kl Hoffman; A Wood; M Navarro Cagigas; Q Yao; Jf Petrosino; W Fisher; G Van Buren
Journal:  Pancreatology       Date:  2020-12-23       Impact factor: 3.996

Review 6.  Gut-central nervous system axis is a target for nutritional therapies.

Authors:  Gustavo D Pimentel; Thayana O Micheletti; Fernanda Pace; José C Rosa; Ronaldo V T Santos; Fabio S Lira
Journal:  Nutr J       Date:  2012-04-10       Impact factor: 3.271

Review 7.  Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review.

Authors:  Margret I Moré; Alexander Swidsinski
Journal:  Clin Exp Gastroenterol       Date:  2015-08-14

8.  Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study.

Authors:  Jacqueline M Lankelma; Lonneke A van Vught; Clara Belzer; Marcus J Schultz; Tom van der Poll; Willem M de Vos; W Joost Wiersinga
Journal:  Intensive Care Med       Date:  2016-11-11       Impact factor: 17.440

9.  Probiotic therapy as a novel approach for allergic disease.

Authors:  Zheng Quan Toh; Anzela Anzela; Mimi L K Tang; Paul V Licciardi
Journal:  Front Pharmacol       Date:  2012-09-21       Impact factor: 5.810

10.  Effects of dietary nutrients on volatile breath metabolites.

Authors:  Olawunmi A Ajibola; David Smith; Patrik Spaněl; Gordon A A Ferns
Journal:  J Nutr Sci       Date:  2013-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.